I have received the exclusive authorization letter from the brand owner in Japan.Is the import business guaranteed to be stable?The truth is,over the past three years,I’ve witnessed at least 20 trading companies face problems due to neglecting the registration details of the "Drug Machinery Law" and cross-border logistics compliance requirements.As a result,their goods were stranded at ports for months,leading to not only losing freight fees but also losing their agency rights.In the B2B sector,an authorization letter is just an entry ticket.The real hurdle lies in the invisible "compliance network".Japanese cosmetics are renowned for their high premiums,but the associated regulatory barriers (such as Japan’s Drug Machinery Law and China’s NMPA registration requirements) are also among the most complex in the industry.If you don’t want to spend all your profits on rectification and return shipments,you must reassess your operational SOPs.

Choice of trade model: general trade vs.A do-or-die match

Before launching an agency business,the first priority is to determine the trade model.This directly determines your sales channels,capital turnover rate,and compliance costs.Many novices blindly pursue "general trade" to cover all channels,but ignore the capital pressure caused by the registration period; others only do cross-border business,but suddenly face a funding crunch due to platform policy adjustments.

The SOP for the entire import process of Japanese cosmetics

Regardless of the mode chosen,standardized operating procedures are the core of risk avoidance.The following is a practical SOP based on general trade (the most challenging),covering key stages from contract signing to customs clearance.

Step 1: Preliminary review and qualification confirmation

Output:

Don’t wait until the goods arrive at the port to check their ingredients.It’s essential to conduct a "pre-audit of ingredients" before signing the contract.

• Ingredientscreening:CheckwhethertheproductingredientlistcontainsingredientsthatareprohibitedinChina(suchascertainhormonesandspecificpreservatives),orwhethertheconcentrationoftheseingredientsexceedsthepermittedlimits.
• Placeoforiginconfirmation:ConfirmThefactoryinformationofMingshangisconsistentwiththeregistrationinformationofforeignmanufacturersinJapan’sPharmaceuticalMachineryLaw.
• Expirationdatemanagement:Japanesecosmeticstypicallyhaveashortshelflife,soit’sessentialtorequirethattheproductiondatebeprintedonthesmallestsalespackaging(asmandatedbytheNationalMedicalProductsAdministration).

Step 2: Document Chain Construction (Core)

Output:

Japanese exporters are accustomed to using "bundled documents",but Chinese customs require "one document for one item".This is the most common reason for cargo delays.

• OriginCertificate:ItmustbeissuedbytheJapanExternalTradeOrganization(JETRO)oradesignatedagency.
• FreeSaleCertificate:ProvethattheproductislegallycirculatingintheJapanesemarket.
• JapanesePharmaceuticalMachineryActRegistrationDocuments:Includingtheingredientlist,themanufacturingmethodbook,MSDS,etc.theyneedtobenotarizedbyanotaryofficeandcertifiedbytheChineseEmbassyorConsulateinJapan.
• PowerofAttorney:ThecompleteauthorizationchainfrombrandmanufacturerstoChineseimportersmustnotbeinterrupted.

Step 3: The Battle to Complete the NMPA Registration Process

Output:

This is the most time-consuming step.It is recommended to entrust an experienced filing agency instead of trying to handle it on your own.

• Usernameregistration:ApplyforanaccountontheCosmeticsRegistrationandFilingInformationServicePlatform.
• Submittheproductformulaforreview:Submittheformulathroughthesystemandwaitforthereview.
• Inspectionandtesting:Submitthesamplestoanationallyaccreditedcosmeticsinspectioninstitutionformicrobiological,hygienicchemical,andtoxicologicaltests.
• Documentstobesubmitted:Uploadproductlabels,salespackaging,efficacysummaries,andothermaterials.

Hidden Minefield: The Overlooked “Authorization Chain” Closed Loop

This is a non-technical trap that many veterans often fall into.Many Chinese agents obtain their products from "general distributors" or "brand operation companies" in Japan,rather than signing contracts directly with the brand owners (joint-stock companies).

When applying for NMPA registration,the Drug Administration Bureau requires the provision of the following documents:Certificate of Authorization at Each LevelAnd it must trace back to the brand holder.If your authorization letter is from a Japanese trading company,and this company cannot provide the authorization documents from the brand owner,or the scope of the authorization provided by the brand owner does not include "exporting to China" or "authorizing third parties to conduct overseas filing",then your filing will be directly rejected.Be sure to request a copy of the complete legal documents authorizing the Japanese party from the brand owner before signing the contract,and confirm the scope of the authorization rights.

Immediate Action List

After reading this article,you can do the following three things this afternoon to identify and address potential risks:

• Auditauthorizationchain:TakeouttheexistingJapanesebrandauthorizationletterinyourhand,checkwhetheritclearlystates"authorizedtoimport/selltoChina",andtracebacktoverifytheauthenticityofthefirst-levelauthorization.
• Checkthelabels:Randomlyselectaninventoryproductandcheckwhethertheproductiondateorexpirationdateisclearlyprintedontheminimumsalespackaging.Ifnot,immediatelystopthegeneraltradeimportplanforthatbatchofproducts.
• SearchfortheHScode:Fortheproductcategoriesyouplantointroduce(suchasserumsandemulsions),checkthelatestcustomssupervisionrequirementstodeterminewhetheryouneedan"ImportGoodsCustomsClearanceForm"oran"ImportLicenseforDual-UseItemsandTechnologies".